• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Nuveen New Jersey Qualified Municipal Fund

    8/27/24 9:11:54 AM ET
    $NXJ
    Finance/Investors Services
    Finance
    Get the next $NXJ alert in real time by email
    SC 13D/A 1 formsc13da.htm FORM SC 13D/A Saba Capital Management, L.P.: Form SC 13D/A - Filed by newsfilecorp.com

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13D/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 10)*

     

    NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND

    (Name of Issuer)

     

    Common Shares, $0.01 par value

    (Title of Class of Securities)

     

    67069Y102

    (CUSIP Number)

    Saba Capital Management, L.P.

    405 Lexington Avenue

    58th Floor

    New York, NY 10174

    Attention: Michael D'Angelo

    (212) 542-4635
    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)

    August 23, 2024

    (Date of Event Which Requires Filing of This Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [ ]

    (Page 1 of 7 Pages)

    ______________________________

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



    1
    NAME OF REPORTING PERSON
    Saba Capital Management, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
      (b) ☐
    3
    SEC USE ONLY
     
    4
    SOURCE OF FUNDS
    OO (see Item 3)
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
     
    ☐
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    7
    SOLE VOTING POWER
    -0-
    8
    SHARED VOTING POWER
    5,979,598
    9
    SOLE DISPOSITIVE POWER
    -0-
    10
    SHARED DISPOSITIVE POWER
    5,979,598
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
    5,979,598
    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
     
    ☐
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    14.50%
    14
    TYPE OF REPORTING PERSON
    PN; IA

    The percentages used herein are calculated based upon 41,232,935 shares of common stock outstanding as of 2/29/24, as disclosed in the company's N-CSR filed 5/3/24



    1
    NAME OF REPORTING PERSON
    Boaz R. Weinstein
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
      (b) ☐
    3
    SEC USE ONLY
     
    4
    SOURCE OF FUNDS
    OO (see Item 3)
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
     
    ☐
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    7
    SOLE VOTING POWER
    -0-
    8
    SHARED VOTING POWER
    5,979,598
    9
    SOLE DISPOSITIVE POWER
    -0-
    10
    SHARED DISPOSITIVE POWER
    5,979,598
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
    5,979,598
    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
     
    ☐
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    14.50%
    14
    TYPE OF REPORTING PERSON
    IN

    The percentages used herein are calculated based upon 41,232,935 shares of common stock outstanding as of 2/29/24, as disclosed in the company's N-CSR filed 5/3/24



    1
    NAME OF REPORTING PERSON
    Saba Capital Management GP, LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
      (b) ☐
    3
    SEC USE ONLY
     
    4
    SOURCE OF FUNDS
    OO (see Item 3)
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
     
    ☐
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    7
    SOLE VOTING POWER
    -0-
    8
    SHARED VOTING POWER
    5,979,598
    9
    SOLE DISPOSITIVE POWER
    -0-
    10
    SHARED DISPOSITIVE POWER
    5,979,598
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
    5,979,598
    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
     
    ☐
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    14.50%
    14
    TYPE OF REPORTING PERSON
    OO

    The percentages used herein are calculated based upon 41,232,935 shares of common stock outstanding as of 2/29/24, as disclosed in the company's N-CSR filed 5/3/24



    Item 1. SECURITY AND ISSUER
       
      This Amendment No. 10 amends and supplements the statement on Schedule 13D filed with the SEC on 4/10/23, as amended by Amendment No.1 filed 5/26/23, Amendment No. 2 filed 8/2/23, Amendment No.3 filed 9/5/23, Amendment No. 4 filed 9/28/23, Amendment No. 5 filed 10/6/23, Amendment No. 6 filed 11/13/23, Amendment No. 7 filed 11/22/23, Amendment No. 8 filed 12/14/23, and Amendment No. 9 filed 5/6/24; with respect to the common shares of NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND. This Amendment No. 10 amends Items 3, 4, 5, 6 and 7, as set forth below.
       
    Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
       
      Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business.  In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time.  Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of approximately $67,810,003 was paid to acquire the Common Shares reported herein.

    Item 4. PURPOSE OF TRANSACTION
       
      On August 23, 2024, Saba Capital Master Fund, Ltd., a private fund advised by Saba Capital, submitted to the Issuer a notice of intent informing the Issuer of its intention to nominate David Littlewood (the "Nominee") as an independent trustee for election to the Board at the Issuer's 2024 annual meeting of shareholders.
     
    The Nominee has entered into a nomination agreement (the "Nominee Agreement") with Saba Capital substantially in the form attached as Exhibit 2 to this Schedule 13D/A whereby the Nominee agreed to stand for election as a trustee of the Issuer in connection with a proxy solicitation which may be conducted in respect of the 2024 Annual Meeting and whereby, Saba Capital has agreed to defend and indemnify the Nominee against, and with respect to, any losses that may be incurred by the Nominee in the event he becomes a party to litigation based on his nomination as a candidate for election to the Board and the solicitation of proxies in support of his election. The foregoing summary of the Nominee Agreement is not complete and is qualified in its entirety by reference to the full text of the form of Nominee Agreement, a copy of which is attached as Exhibit 2 and is incorporated by reference herein.



    Item 5. INTEREST IN SECURITIES OF THE ISSUER
       
    (a) See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons.  The percentages used herein are calculated based upon 41,232,935 shares of common stock outstanding as of 2/29/24, as disclosed in the company's N-CSR filed 5/3/24
       
    (b) See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
       
    (c) No transactions in the Common Shares within the past sixty days.
       
    (d) The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares.
       
    (e) Not applicable.
       
    Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
       
      Item 6 is hereby amended and supplemented by the addition of the following:
       
      The Reporting Persons' response to Item 4 is incorporated by reference into this Item 6.

    Item 7. MATERIAL TO BE FILED AS EXHIBITS
       
    Exhibit 2: Form of Nominee Agreement


    SIGNATURES

    After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Date:  August 27, 2024

      SABA CAPITAL MANAGEMENT, L.P.
     
    By:  /s/ Michael D'Angelo
      Name: Michael D'Angelo
    Title: Chief Compliance Officer
       
       
      SABA CAPITAL MANAGEMENT GP, LLC
     
    By:  /s/ Michael D'Angelo
    Name: Michael D'Angelo
    Title: Authorized Signatory
       
       
      BOAZ R. WEINSTEIN
     
    By:  /s/ Michael D'Angelo
      Name: Michael D'Angelo
      Title: Attorney-in-fact*
     
     
    * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823
     


    Get the next $NXJ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NXJ

    DatePrice TargetRatingAnalyst
    More analyst ratings